Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.

@article{CuppVickery2001KetoconazoleinducedCC,
  title={Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.},
  author={Jill R. Cupp-Vickery and Carlos Garc{\'i}a and Andrew Hofacre and Kathleen Mcgee-Estrada},
  journal={Journal of molecular biology},
  year={2001},
  volume={311 1},
  pages={101-10}
}
The azole-based P450 inhibitor ketoconazole is used to treat fungal infections and functions by blocking ergosterol biosynthesis in yeast. Ketoconazole binds to mammalian P450 enzymes and this can result in drug-drug interactions and lead to liver damage. To identify protein-drug interactions that contribute to binding specificity and affinity, we determined the crystal structure of ketoconazole complexed with P450eryF. In the P450eryF/ketoconazole structure, the azole moiety and nearby rings… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

Similar Papers

Loading similar papers…